CVM Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2024Q4

-3.300

-31.25%

Estimates Revision

The market is revising No Change the revenue expectations for CEL-SCI Corporation (CVM) for FY2026, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -42.90%.

Revenue Estimates for FY2026

No Change

0.00%

In Past 3 Month

EPS Estimates for FY2026

No Change

0.00%

In Past 3 Month

Stock Price

Go Down

-42.90%

In Past 3 Month

Valuation Metrics

The current forward P/E ratio for CEL-SCI Corp (CVM.A) is -1.47, compared to its 5-year average forward P/E of -11.06. For a more detailed relative valuation and DCF analysis to assess CEL-SCI Corp 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-11.06

Current PE

-1.47

Overvalued PE

8.65

Undervalued PE

-30.76

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

-4.80

Current EV/EBITDA

-1.86

Overvalued EV/EBITDA

1.89

Undervalued EV/EBITDA

-11.49

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

258.98

Current PS

4.62

Overvalued PS

945.61

Undervalued PS

-427.65

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

CVM News & Events

Events Timeline

No data

News

2.0

2025-12-29Newsfilter

CEL-SCI Files for Breakthrough Designation for Multikine in Saudi Arabia, Plans 212-Patient Enrollment in 2026

2.0

2025-09-19NASDAQ.COM

Emerging Growth Stocks Experience Significant Gains in After-Hours Trading

4.5

2025-08-28Benzinga

Stock Market Update: Nvidia Weighs on Nasdaq Futures—Attention on Dollar General, Dell, and Best Buy

People Also Watch

Frequently Asked Questions

What is CEL-SCI Corp (CVM) stock price today?

The current price of CVM is 5.67 USD — it has decreased -3.24 % in the last trading day.

What is CEL-SCI Corp (CVM)'s business?

CEL-SCI Corporation is a late clinical-stage biotechnology company. It is engaged in research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body’s natural defense system. It is focused on the development of product candidates and technologies, including Multikine and Ligand Epitope Antigen Presentation System technology (LEAPS). Multikine (Leukocyte Interleukin, Injection), a true first-line cancer therapy, which is designed to help the immune system target the tumor at a time when the immune system is still relatively intact and thereby thought to be better able to mount an attack on the tumor. LEAPS is designed to stimulate the human immune system to more effectively fight bacterial, viral and parasitic infections as well as autoimmune conditions, allergies, transplantation rejection and cancer, when it cannot do so on its own. The LEAPS candidates include CEL-2000, CEL-4000 and DerG-PG275(Cit) (aka, CEL-5000).

What is the price predicton of CVM Stock?

Wall Street analysts forecast CVM stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for CVM is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is CEL-SCI Corp (CVM)'s revenue for the last quarter?

CEL-SCI Corp revenue for the last quarter amounts to 0.00 USD, decreased % YoY.

What is CEL-SCI Corp (CVM)'s earnings per share (EPS) for the last quarter?

CEL-SCI Corp. EPS for the last quarter amounts to -0.86 USD, decreased -71.04 % YoY.

What changes have occurred in the market's expectations for CEL-SCI Corp (CVM)'s fundamentals?

How many employees does CEL-SCI Corp (CVM). have?

CEL-SCI Corp (CVM) has 44 emplpoyees as of January 09 2026.

What is CEL-SCI Corp (CVM) market cap?

Today CVM has the market capitalization of 47.93M USD.